Low riskFDA DrugClass III

Asclemed Lidolog Kit lidocaine injection recalled for barcode labeling defect

Asclemed USA Inc. is recalling Lidolog Kit, which contains lidocaine injection, because the label wrap covers the barcode, making it difficult to scan. This labeling defect affects 18 kits distributed in Tennessee.

From the FDA notice · Read the official notice ↗

What to do

  1. Check your inventory for Lidolog Kit lot 070126X1 with expiration 12/31/2027.
  2. Do not use affected kits if the barcode cannot be scanned clearly.
  3. Contact your supplier or Asclemed USA Inc. for return or replacement instructions.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
Sold in
Within U.S. - Tennessee
Made for
Adults (0 months and older)

Details

Units affected
18 kits
Illnesses reported
None reported
Manufactured in
379 Van Ness Ave Ste 1403, N/A, Torrance, CA, United States
Classification
Class III
Recall number
D-0713-2026

In the FDA's words

Description
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01. Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan Lot: 070126X1, Exp. 12/31/2027. Distribution: Within U.S. - Tennessee Affected quantity: 18 kits
Hazard
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan

Related topics